関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Hydrochloric Acid | HCID 313 | — |
| 反応物 | Piperazine | HCID 4837 | — |
| 反応物 | 3,5-Dichloro-4-(1-methylethylamino)pyridazine | HCID 10822136 | — |
| 溶媒 | O-Xylene | HCID 7237 | — |
| 生成物 | 1-[5-Chloro-4-(1-methylethyl)amino-3-pyridazinyl]piperazine | HCID 21477673 | — |
反応手順
A mixture of 3,5-dichloro-4-(1-methylethyl)aminopyridazine (PREPARATION 41, 1.77 g) and piperazine (2.96 g) in xylene (18 ml) is refluxed for 40 hr. The mixture is cooled and then treated with concentrated hydrochloric acid (8 ml). After further cooling, a precipitate forms and the organic liquid is separated. The aqueous phase is diluted with an excess of a solution of aqueous sodium hydroxide (10%) and then is extracted with chloroform (3×). The combined organic extracts are washed with water, then saline, dried over sodium sulfate, and concentrated to an oil. The crude product is flash chromatographed on silica gel eluting with methanol. The appropriate fractions are pooled and concentrated to give the title compound, NMR (CDCl3) 1.20, 3.04, 3.18, 4.46, 4.73 and 8.50 δ; CMR (CDCl3) 24.0, 44.3, 45.9, 50.2, 118.2, 135.8, 148.3 and 155.4 δ.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US05686610 |
|---|
| 出典データセット | uspto-grants-1997_11 |
|---|
| ORD ID | ord-23c28f4adb4949fd889a672ed6288880 |
|---|
| 出典メモ | uspto-grants-1997_11 |
|---|